Skip to main content

Nanoviricides, Inc.

NNVC
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001379006

No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Nanoviricides, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of NNVC: Q1 2025 compared with Q2 2025
MeasureQ1 2025Of which not filed for Q2 2025Q2 2025Change
Holders37133−3
Shares1.49M2651.34M−150.1K (−10.1%)
Value$1.74M$311$1.87M+$132.6K (+7.6%)

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Nanoviricides, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to NNVC in Q2 2025
InstitutionSharesValue% of portfolio
Foundations Investment Advisors, LLC10,000$14.0K0.00%
SBI Securities Co., Ltd.300$4200.00%
Atlantic Union Bankshares Corp265$3710.00%
Raymond James Financial Inc44$620.00%
FMR LLC36$500.00%

Sold out (8)

Institutions that held Nanoviricides, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of NNVC in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Compagnie Lombard Odier SCmA200,000$234.0K
Integrated Wealth Concepts LLC26,035$30.5K
Wealth Enhancement Advisory Services, LLC22,138$25.9K
Stifel Financial Corp21,200$24.8K
Tower Research Capital LLC (TRC)4,663$5.46K
IFP Advisors, Inc1,000$1.17K
Federation des caisses Desjardins du Quebec210$246
Ameriflex Group, Inc.100$117

Not filed for Q2 2025 yet (1)

Institutions that held Nanoviricides, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NNVC in Q1 2025 that haven't filed for Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Sandy Spring Bank265$311